Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: US Neurol. 2015 Fall;11(2):102–105. doi: 10.17925/USN.2015.11.02.102

Figure 1.

Figure 1

Platform for AD drug screening in human neural progenitor cells with FAD mutations in a 3D culture system, which successfully reproduce human AD pathogenesis (amyloid plaques-driven tauopathy).